Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (2)
Scientific Reports (1)
BJC Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Health care

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Muhammad Zaki Hidayatullah Fadlullah Clear advanced filters

Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

Nabil F. Saba
Conor E. Steuer
Christine H. Chung
Amendments and Corrections02 Jul 2024
Nature Medicine

Volume: 30, P: 2373
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

In a phase 2 trial of pembrolizumab and cabozantinib in patients with advanced head and neck cancer, a high clinical benefit rate was achieved, which positively correlated with levels of CD8⁺ T cell infiltration but not tumor mutational burden.

Nabil F. Saba
Conor E. Steuer
Christine H. Chung
Research03 Apr 2023
Nature Medicine

Volume: 29, P: 880-887
The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors

Hui Mei Lee
Gregory Michael Kelly
Sok Ching Cheong
ResearchOpen Access20 Feb 2019
Scientific Reports

Volume: 9, P: 1-10
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response

Zoe Quandt
Saya Jacob
Adil I. Daud
ResearchOpen Access24 Jun 2024
BJC Reports

Volume: 2, P: 1-10